Developmental changes in neuronal responsiveness to the CNS myelin-associated neurite growth inhibitor NI-35/250.
The extent of fibre regeneration in the adult injured vertebrate nervous system appears to be primarily determined by the local environment. Thus, the failure of axon regrowth in the central nervous system (CNS) is crucially influenced by the presence of the myelin-associated neurite growth inhibitor NI-35/250 and possibly also by molecules such as the myelin-associated glycoprotein and the proteoglycans. Developmental time course studies have shown that the capacity for regeneration declines sharply with the appearance of mature oligodendrocytes and myelin, which indicates a role of NI-35/250 in restricting CNS regeneration and plasticity. However, recent in vitro and in vivo studies showed that embryonic neurons are capable of extending fibres on and in adult CNS tissue apparently unaffected by myelinated areas. A possible explanation is that very immature neurons have yet to express the appropriate receptors and response mechanisms for factors that normally induce growth inhibition at a later stage of development. Here we report that embryonic rat dorsal root ganglion and chick retinal ganglion cells display different sensitivity to bovine NI-35/250 compared with mature neurons. In older neurons NI-35/250 could evoke long-lasting collapse responses accompanied by a large increase in the intracellular calcium level, persisting for several minutes. In contrast, their embryonic counterparts collapsed only transiently when exposed to NI-35/250, and increases in intracellular calcium concentration were small and transient. Calcium influx induced experimentally by the calcium ionophore A23187 revealed that it was not the maximal size of the calcium increase but rather the duration of elevated calcium concentration that was the most important determinant for subsequent morphological alterations of the growth cone. Our data further suggest that developing neurons acquire their complete sensitivity for NI-35/250 around the time of myelination.
Bandtlow
C E
CE
Brain Research Institute, University of Zurich, Switzerland.
Löschinger
J
J
D000367:Age Factors; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D048429:Cell Size; D002490:Central Nervous System / Q000166:cytology*; D002642:Chick Embryo; D005333:Fetus / Q000166:cytology; D005727:Ganglia, Spinal / Q000166:cytology; D006131:Growth Inhibitors / Q000494:pharmacology*; D009186:Myelin Sheath / Q000502:physiology*; D016501:Neurites / Q000502:physiology*; D009474:Neurons / Q000166:cytology* / Q000187:drug effects / Q000648:ultrastructure; D051381:Rats; D011917:Rats, Inbred Lew; D012165:Retinal Ganglion Cells / Q000166:cytology / Q000187:drug effects
D006131:Growth Inhibitors; D002118:Calcium